The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Following a review by the TGA, medicines and other therapeutic goods can be suspended from the Australian Register of Therapeutic Goods. For listed and registered medicines, these suspensions are made by the Secretary under section 29D of the Therapeutic Goods Act 1989 - external site (the Act).
If a suspension occurs because of a safety concern, the TGA considers whether other actions including a recall are necessary and takes those actions when required. Any safety-related actions will appear under 'Further information'.
The reasons for a suspension are stated in the database under 'Grounds for suspension'.